Longeveron Q4 net loss $4.5M, FY 2022 loss $18.8M; cash $19.6M, runway into H1 2024

Longeveron Inc.

Q4 2022 net loss $4.5M ($0.21/share) vs $4.1M; full year loss $18.8M ($0.90/share) vs $17.0M.
Revenue Q4 $0.1M, full year $1.2M (flat vs $1.3M); clinical trial revenue up 29% to $0.9M.
Cash and short-term investments $19.6M at Dec 31, 2022, down from $35.0M; funds operations into H1 2024.
Completed enrollment in Phase 2a Alzheimer's trial (CLEAR MIND, 48 patients); topline results expected early 2024.
Initiated Phase 2 Aging-Related Frailty trial in Japan; first patient randomization expected Q1 2023.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Longeveron Inc. reported fourth quarter and full year of 2022 results: revenue Revenue in the fourth quarter 2022 was $0.1 million compared to $0.2 million in the same period in 2021. Revenue for ful, net income Net loss was $4.5 million in the fourth quarter of 2022 compared to $4.1 million for the same period in 2021. Net loss f.

Period: fourth quarter and full year of 2022
Revenue: Revenue in the fourth quarter 2022 was $0.1 million compared to $0.2 million in the same period in 2021. Revenue for ful
Net income: Net loss was $4.5 million in the fourth quarter of 2022 compared to $4.1 million for the same period in 2021. Net loss f
Result: reported results

Exact text from the filing

On March 10, 2023, the Company announced financial and operating results as of and for the three and twelve months ended December 31, 2022 and 2021.

View on SEC.gov

Browse all earnings releases →

Longeveron Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-019022

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.